Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

Presentation TCT 2021

LAAO in 2030: My 5 Top Predictions for the Field

Presenter: David Holmes Jr.

November 06, 2021

Presentation TCT 2021

Closing Complex Anatomies LAAO Devices

Presenter: Brian Whisenant

November 06, 2021

Presentation TCT 2021

Patient Anatomical Selection for LAAO: Should There Be Imaging Consensus Anatomical Criteria?

Presenter: Dee Dee Wang

November 06, 2021

Presentation TCT 2021

A Case Where I Was Really Happy to Have Pre-Procedural CT Planning as Additive Planning for Intraprocedural TEE

Presenter: Dee Dee Wang

November 06, 2021

Presentation TCT 2021

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

Presenter: Renato D. Lopes

November 06, 2021

Presentation TCT 2021

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

Presenter: Brijeshwar Maini

November 06, 2021

Presentation TCT 2021

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Presenter: Mohamad A. Alkhouli

November 06, 2021

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

Presenter: Jacqueline Saw

November 06, 2021

Presentation TCT 2021

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Presenter: Roberto Galea

November 06, 2021

News Conference News TCT 2021

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

Todd Neale

November 06, 2021

Presentation TCT 2021

Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective

Presenter: Kan Fang

November 05, 2021

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Todd Neale

November 05, 2021

Presentation TCT 2021

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Presenter: Pavel Osmancik

November 05, 2021

Presentation TCT 2021

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

Presenter: Dhanunjaya Lakkireddy

November 05, 2021

Presentation TCT 2021

TCT 567: Unusual Case of Severe Left Circumflex Coronary Artery Stenosis Following Left Atrial Appendage Closure

Presenter: Naeem Tahirkheli

November 04, 2021

Presentation TCT 2021

TCT 566: Residual Left Atrial Appendage Leak Following Percutaneous Left Atrial Appendage Occlusion: An Arising Problem of The Emerging Procedure

Presenter: Chanavuth Kanitsoraphan

November 04, 2021

Presentation TCT 2021

TCT 565: Left Atrial Intramural Hematoma

Presenter: Aditya Kesari

November 04, 2021

Presentation TCT 2021

TCT 564: A New Perspective: Intracardiac Echocardiographic Guidance for the Implantation of a Left Atrial Appendage Occluder Device (Watchman) with a Leadless Pacemaker (Micra)

Presenter: Kristen Brown

November 04, 2021

Presentation TCT 2021

TCT 563: Left Atrial Appendage Occlusion via Transhepatic Access in a Patient With Inferior Vena Cava Occlusion

Presenter: Ahmed El Shaer

November 04, 2021

Advertisement

LAAO in 2030: My 5 Top Predictions for the Field

Closing Complex Anatomies LAAO Devices

Patient Anatomical Selection for LAAO: Should There Be Imaging Consensus Anatomical Criteria?

A Case Where I Was Really Happy to Have Pre-Procedural CT Planning as Additive Planning for Intraprocedural TEE

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Oral Anticoagulation Should Be the Default Strategy After LAAC

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

TCT 567: Unusual Case of Severe Left Circumflex Coronary Artery Stenosis Following Left Atrial Appendage Closure

TCT 566: Residual Left Atrial Appendage Leak Following Percutaneous Left Atrial Appendage Occlusion: An Arising Problem of The Emerging Procedure

TCT 565: Left Atrial Intramural Hematoma

TCT 564: A New Perspective: Intracardiac Echocardiographic Guidance for the Implantation of a Left Atrial Appendage Occluder Device (Watchman) with a Leadless Pacemaker (Micra)

TCT 563: Left Atrial Appendage Occlusion via Transhepatic Access in a Patient With Inferior Vena Cava Occlusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content